跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lemard-20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lemard-20
Approved
STANDARD
Lemard-20
Ipca Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
da0808261c9cd5c6
Company
Ipca Laboratories Limited
Type
Standard
Approval Details
Approval Id
da0808261c9cd5c6
Drug Approval Philippines Name
Lemard-20
Product Name
Lemard-20
Registration Number
DR-XY48555
Brand Name
Lemard-20
Generic Name
Leflunomide
Dosage Form
Film-Coated Tablet
Dosage Strength
20 mg
Manufacturer
Ipca Laboratories Limited
Importer
Blue Global (FZE)
Distributor
Blue Global (FZE)
Company Detail Path
/organization/ipca-laboratories-limited
Issuance Date
26 July 2024
Expiry Date
06 January 2028
Pharmacologic Category
Immunosuppressant
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
da0808261c9cd5c6
Type
Standard
Back to Philippines FDA Approvals